Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breast cancer: Epidemiology, risk factors and screening
Hangcheng Xu, Binghe Xu
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 6, pp. 565-583
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy
Enar Jumaniyazova, А. V. Lokhonina, D. Sh. Dzhalilova, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 342-342
Open Access | Times Cited: 1
Post-traumatic growth experience of breast cancer patients: A qualitative systematic review and meta-synthesis
S D Huang, Min Huang, Fang Long, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316108-e0316108
Open Access | Times Cited: 1
Trophoblast Cell Surface Antigen Imprinted Polymer Nanoparticles for Breast Cancer Therapy
Lila Louadj, Perla Benghouzi, Romain Morichon, et al.
ACS Applied Nano Materials (2025) Vol. 8, Iss. 1, pp. 329-339
Closed Access
Induction of DNA damage and growth arrest by citalopram in breast cancer cells mediated via activation of Gadd45a and apoptotic genes
Mohammed Salama, Aymen Elamin, Magda Youssif, et al.
Ultrastructural Pathology (2025), pp. 1-12
Closed Access
The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study
Li Yu, Yu Meng, Ming Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
LncRNA TCL6 regulates miR-876–5p/MYL2 axis to suppress breast cancer progression
Yaobang Liu, Haipeng Li, Dahai Chai, et al.
Translational Oncology (2025) Vol. 53, pp. 102210-102210
Closed Access
Health-Related Quality of Life and Disease Acceptance Among Women with Breast Cancer Pre- and Post-Neoadjuvant Chemotherapy
Magdalena Konieczny, Jolanta Sawicka, Izabela Gąska, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 497-497
Open Access
Long-term outcomes of volume de-escalation for breast nodal irradiation
Riccardo Ray Colciago, Federica Ferrario, C. Chissotti, et al.
Breast Cancer Research and Treatment (2025)
Open Access
Development and characterization of ethosomes of Acacia senegal for improved topical treatment of breast cancer
Sunil T. Galatage, Arehalli S. Manjappa, Kameswara Rao Sankula, et al.
Next Materials (2025) Vol. 8, pp. 100556-100556
Closed Access
The prediction power of thymidine phosphorylase and IL-6 in the relapse of breast cancer
Ahmed Hussein Zwamel, Hind M. Mousa, Bushra A. M. Abdul Azeez, et al.
Polski Merkuriusz Lekarski (2025) Vol. 53, Iss. 1, pp. 88-93
Closed Access
Genomic Landscape of Breast Cancer: Study Across Diverse Ethnic Groups
Asbiel Felipe Garibaldi-Ríos, Luis E. Figuera, Guillermo Moisés Zúñiga‐González, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 86-86
Open Access
Triple synergistic enhancement of breast cancer treatment via chemotherapy, chemodynamic therapy, and tumor starvation therapy driven by lipid-COF nanoparticles
Yinghao Sun, Zhenkun Ren, Zhiruo Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Innovative approaches in breast cancer therapy: repurposing nanocarriers for enhanced outcomes
Sana Naaz Siddiqui, Md. Faheem Haider, M.A. Rahman
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Benign and Malignant Breast Lesions: Differentiation Using Microstructural Metrics Derived from Time-Dependent Diffusion MRI
Yun Su, Ya Qiu, X M Huang, et al.
Radiology Imaging Cancer (2025) Vol. 7, Iss. 3
Closed Access
Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis.
Dechao Feng, Yuhan Xiao, Jie Wang, et al.
PubMed (2024) Vol. 36, Iss. 3, pp. 341-350
Closed Access | Times Cited: 4
A Case Series Analysis of 1200 Breast Cancer Patients with 12 Years Follow-Up from a Single Hospital in Iran
Hamid Soori, Abdulrahman Abdullateef, Lawal Olumuyiwa Mashood, et al.
Indian Journal of Surgery (2025)
Closed Access
Chen’s peiyuan tang and premature ovarian failure: unveiling the mechanisms through network pharmacology
Xiao Yang, Yiming Mao, Chong Yao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
CSO-CNN: Cat Swarm Optimization-guided Convolutional Neural Network for Mobile Detection of Breast Cancer
Xiaoyan Jiang, Zuojin Hu, Zhaozhao Xu
Mobile Networks and Applications (2024)
Closed Access | Times Cited: 2
Inetetamab for injection in combination with vinorelbine weekly or every three weeks in HER2-positive metastatic breast cancer: A multicenter, randomized, phase II clinical trial
Xiying Shao, Ning Xie, Zhanhong Chen, et al.
Journal of Translational Internal Medicine (2024) Vol. 12, Iss. 5, pp. 466-477
Open Access | Times Cited: 2
PMAIP1-mediated glucose metabolism and its impact on the tumor microenvironment in breast cancer: Integration of multi-omics analysis and experimental validation
Yidong Zhang, Hang Xu, Xuedan Han, et al.
Translational Oncology (2024) Vol. 52, pp. 102267-102267
Closed Access | Times Cited: 2
A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer
Pin Zhang, Lin Wang, Yueying Zhen, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 1, pp. 46-54
Open Access | Times Cited: 1
A Retrospective Analysis of Diagnostic Breast Imaging Outcomes in Young Women at a Tertiary Care Center
Navdeep Dehar, Doris Jabs, Wilma M. Hopman, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3939-3948
Open Access | Times Cited: 1
Pan-Cancer Screening and Validation of CALU’s Role in EMT Regulation and Tumor Microenvironment in Triple-Negative Breast Cancer
Shiliang Chen, Dan Hu, T L Chen, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6743-6764
Open Access | Times Cited: 1
Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRI
Yi Dai, Chun Lian, Zhuo Zhang, et al.
Journal of Magnetic Resonance Imaging (2024)
Open Access | Times Cited: 1
MDM2 Gene rs2279744 Polymorphism and Breast Cancer Risk: Evidence from Meta-Analysis and Meta-Regression Analysis
Mohammad Masoud Eslami, Payam Mohammadi, Amir Samii, et al.
Indian Journal of Gynecologic Oncology (2024) Vol. 22, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top